Optimizing Genetic Testing Prior Authorizations with Change Healthcare Clearinghouse

Navigating the complexities of prior authorization for genetic testing demands robust integration. Klivira connects your genetic testing workflows directly with the Change Healthcare Clearinghouse to accelerate approvals.

For revenue cycle directors and prior authorization coordinators managing genetic testing services, the intersection of high-cost diagnostics and complex payer rules presents significant operational challenges. Leveraging the Change Healthcare Clearinghouse for electronic prior authorization (ePA) is critical for efficiency, yet requires specialized integration to handle the unique demands of genomics.

The Unique Prior Authorization Landscape for Genetic Testing

Genetic testing, encompassing hereditary cancer panels, prenatal diagnostics, and pharmacogenomics, is characterized by rapidly evolving clinical guidelines and high unit costs. This often triggers intensive prior authorization requirements, frequently routed through specialized Radiology Benefit Managers (RBMs) such as eviCore and Avalon Healthcare Services. Effective PA automation must account for these specific pathways and the detailed clinical documentation required.

Klivira's Integration with Change Healthcare for Genetic Testing PA

Klivira integrates directly with the Change Healthcare Clearinghouse, leveraging its robust infrastructure for HIPAA X12 278 transactions. This enables the electronic submission of prior authorization requests for genetic tests, streamlining communication between your EMR, Klivira, Change Healthcare, and ultimately, the payer or RBM. Our platform ensures that the specific data elements required for genetic testing PAs are accurately transmitted.

Key Prior Authorization Triggers for Genetic Testing Services

  • Hereditary Cancer Panels (e.g., BRCA1/2, Lynch Syndrome panels)
  • Non-Invasive Prenatal Testing (NIPT) and other prenatal genetic screens
  • Pharmacogenomic (PGx) testing for medication response prediction
  • Whole Exome Sequencing (WES) and Whole Genome Sequencing (WGS)
  • Advanced diagnostic lab services for rare genetic conditions

EMR and Payer Touchpoints in Genetic Testing Workflows

Genetic testing prior authorization workflows typically originate with an EMR order (e.g., Epic, Cerner) for a specific genetic test. Klivira intercepts these orders, aggregates necessary clinical documentation (e.g., genetic counseling notes, family history, pathology reports), and routes the X12 278 request via Change Healthcare. Payer responses, including those from RBMs, are then captured and reconciled within your EMR, ensuring a closed-loop process.

Aligning with Clinical Guidelines for Genetic Testing Approvals

Successful prior authorizations for genetic testing are heavily dependent on demonstrating medical necessity aligned with established clinical guidelines. Klivira helps structure documentation to support criteria from bodies like the National Comprehensive Cancer Network (NCCN) for hereditary cancer, the American College of Medical Genetics and Genomics (ACMG), and the American College of Obstetricians and Gynecologists (ACOG) for prenatal testing. This evidence-grounded approach significantly improves approval rates.

Frequently asked questions

How does Klivira use Change Healthcare for genetic testing prior authorizations?

Klivira integrates with Change Healthcare as a secure conduit for electronic prior authorization (ePA) requests. For genetic testing, Klivira compiles the necessary clinical data from your EMR and submits it as an X12 278 transaction through Change Healthcare to the relevant payer or RBM, streamlining the submission and response process.

What specific genetic tests benefit most from this integration?

High-cost and frequently prior-authorized genetic tests, such as hereditary cancer panels (e.g., BRCA), non-invasive prenatal testing (NIPT), and pharmacogenomic assays, benefit significantly. The integration accelerates the submission of these complex requests, reducing manual effort and potential delays.

How does this integration handle RBMs like eviCore or Avalon for genetic testing?

Many genetic testing PAs are delegated to RBMs. Klivira's integration with Change Healthcare facilitates the initial X12 278 submission, which is then routed by the payer or clearinghouse to the appropriate RBM. Klivira tracks the request and captures responses from these entities, ensuring comprehensive oversight of the PA workflow.

What EMR documentation is typically required for genetic testing PAs?

Genetic testing prior authorizations often require detailed clinical notes, genetic counseling reports, family history documentation, relevant pathology reports (for cancer panels), and physician orders. Klivira assists in identifying and extracting these critical data points from your EMR to support the X12 278 submission.

Related coverage

Other genetic-testing prior auth workflows

Ready to automate this workflow for this specialty?

See how Klivira automates prior authorizations for your team.

Request a demo